|
|
|
|
|
|
|
|
|
|
Previous: AMPEX CORP /DE/, 10-Q, EX-4.2, 2000-08-14 |
Next: ZOLL MEDICAL CORPORATION, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S
CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JUNE 30, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 14,784
<SECURITIES> 12,429
<RECEIVABLES> 2,212
<ALLOWANCES> (285)
<INVENTORY> 3,044
<CURRENT-ASSETS> 34,762
<PP&E> 9,328
<DEPRECIATION> 2,849
<TOTAL-ASSETS> 79,049
<CURRENT-LIABILITIES> 16,513
<BONDS> 43,607
38,744
0
<COMMON> 571
<OTHER-SE> (44,463)
<TOTAL-LIABILITY-AND-EQUITY> 79,049
<SALES> 2,990
<TOTAL-REVENUES> 7,065
<CGS> 2,598
<TOTAL-COSTS> 13,606
<OTHER-EXPENSES> 223
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,383
<INCOME-PRETAX> (8,020)
<INCOME-TAX> 365
<INCOME-CONTINUING> (8,385)
<DISCONTINUED> 693
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,692)
<EPS-BASIC> (0.14)
<EPS-DILUTED> (0.14)
</TABLE>
|
|